Last reviewed · How we verify

NCT04382105

Evaluation of Saliva IL-6 Levels and Periodontitis

Completed Last updated 24 November 2020
What this trial tests

trial testing Observation of salivary IL-6 levels in Periodontal Diseases in 287 participants. Completed in 25 September 2019.

Timeline
8 November 2015
Primary endpoint
15 September 2019
25 September 2019

Quick facts

Lead sponsorUniversity of Messina
StatusCompleted
Study typeOBSERVATIONAL
Enrollment287
Start date8 November 2015
Primary completion15 September 2019
Estimated completion25 September 2019
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

University of Messina

Who can join

Adults 35 to 65, any sex, with Periodontal Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study was to analyze the association between salivary IL-6 levels in patients with periodontitis. Furthermore, the objective was to determine if the periodontitis influenced salivary IL-6 levels

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Periodontal Diseases

Currently open trials in the same condition.

Other University of Messina trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04382105.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing